By Alexandra Saintpierre Published on 02/25/2022 at 07:13 Photo credit © Reuters (Boursier.com) — For 2021, the turnover ofAures Technologies is in line with the Group’s expectations. It stands at 99.7 million euros, up 14.2% (+15.2% at constant…
Dell Technologies announced strong results for its staggered fiscal year 2022 thanks to record PC shipments and continued growth across all of the group’s business units. The company’s business has thrived during the pandemic, thanks to the rise of remote working, helping it beat revenue estimates for eight consecutive quarters. However, the year is overshadowed…
By Jean-Noel Legalland Published on 02/25/2022 at 1:47 p.m. Photo credit © Reuters (Boursier.com) — Dell Technologies plunged 10% before market on Wall Street, on disappointing profitability forecasts. The Texas computer group anticipates, for the quarter ended in…
Montrouge, France, February 24 (10:30 p.m. CET), 2022 DBV Technologies will publish his results financial for the year 2021 and will do the point on his activities March 3, 2022 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that the company will host a conference…
Thursday, February 24, 2022 2021 revenue in line with Group expectations: €99.7 million, up 14.2% (+15.2% at constant exchange rates) As expected, the Group’s activity during the last quarter of 2021 was strongly affected by the shortage of electronic components and the transport crisis. However, despite this troubled context, the Group posted a 14.2% increase…
Marketzone with MT Newswires 2022 All the news about MAXAR TECHNOLOGIES INC. Analyst Recommendations for MAXAR TECHNOLOGIES INC. 2021 turnover 1,763M – 1,558M 2021 net result -22.2M – -19.6M Net debt 2021 2,119M – 1,873M PER 2021 -82.7x 2021 performance 0.12% Capitalization 1,965M 1,965M…
(AOF) – Mauna Kea Technologies announces that, as part of its collaboration with Johnson & Johnson’s Lung Cancer Initiative (LCI), initial patient recruitment has begun in a prospective, multicenter, open-label, one-time clinical feasibility study. single arm, sponsored by the LCI. “The study will validate Cellvizio as a real-time biopsy guidance tool during robotic bronchoscopic navigation…
Faced with the persistent situation observed over the past two years, companies around the world have had to undergo a rapid digital transformation in order to present a new digitized version of themselves to their stakeholders. However, the adoption of new technologies and new business models often comes up against outdated or unsuitable legacy systems…
If a sales manager or other executive in your company isn’t talking about artificial intelligence (AI) these days, it’s time to ask them why and get them involved. Excuses are increasingly rare when it comes to switching to advanced processing technologies. Solutions such as artificial intelligence are now readily available, and businesses no longer need…
CL Published on 02/15/2022 at 07:17 Photo credit © Reuters (Boursier.com) — DBV Technologiesa clinical-stage biopharmaceutical company, announced that Daniel Tassé, Chief Executive Officer, will be presenting at the 11th Annual SVB Leerink Global Healthcare Conference…
(CercleFinance.com) – Genomic Vision announces that its technology has been adopted by the Department of Cellular and Molecular Biology at the University of Florida to study the mechanisms of DNA replication and replicative stress. Indeed, researchers at the University of Florida have obtained funding from the National Institute for Health (NIH) to acquire the technology…
(CercleFinance.com) – Genomic Vision announces that its technology has been adopted by the Department of Cellular and Molecular Biology at the University of Florida to study the mechanisms of DNA replication and replicative stress. Indeed, researchers at the University of Florida have obtained funding from the National Institute for Health (NIH) to acquire the technology…
